NLSP Nilai Total Aset Perusahaan NLS Pharma

NLSP (nlspharma.com) - tandha merek perusahaan

The Swiss biopharma company NLS Pharmaceutics AG (NLSP) faces the threat of failure in its ADHD drug trials and requires constant funding. The business relies on the development of sleep disorder therapies, anticipating high profits upon obtaining patents. This chart of stock quotes on GURU.Markets shows that total assets amount to 7.93. The firm's environmental profile is limited to standard chemical disposal in laboratories.

NLSP (NLS Pharmaceutics) riwayat Total Aset Perusahaan saka 04.07.2022 nganti 31.10.2025

Rincian analitis lan laporan data perusahaan nlspharma.com (NLSP)

- rega saiki lan proyeksi nilai saham:
Bagan kutipan NLS Pharmaceutics|NLSP - Bagan rega target
- data kapitalisasi pasar:
Biji pasar NLS Pharmaceutics|NLSP - Nilai Perusahaan
- statistik nilai buku emiten:
Nilai Akuntansi Saham NLS Pharmaceutics|NLSP - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku nlspharma.com|NLSP - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi NLS Pharmaceutics AG|NLSP - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas NLS Pharmaceutics|NLSP - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku NLS Pharmaceutics|NLSP - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan NLS Pharmaceutics|Rasio likuiditas darurat nlspharma.com
- indikator pendapatan resik lan kelipatan nilai:
NLSP - Bathi resik
Pambiji fundamental:NLS Pharmaceutics AG
Produk sing diprodhuksi NLS Pharmaceutics Ltd.

Striking a balance between operational risks and return on capital while developing drugs for sleep disorders requires precise resource monitoring; therefore, by analyzing all company resources using a reverse ROA method, the current value of assets is tracked to distinguish genuine asset base growth from inflationary cost bloating, confirming the financial stability of NLS Pharmaceutics AG (NLSP) in protecting its innovative molecules.

Pesaing wigati

Nilai Total Aset Perusahaan JAZZ (jazzpharma.com)|Aset Agregat Perusahaan Cytokinetics, Incorporated|PTC Therapeutics Inc - Nilai Total Aset Perusahaan|Total Aset Perusahaan SRRK|CNTA (Centessa Corp) - Nilai Agregat Aset|Total Aset Perusahaan DYN (Dyne Therapeutics, Inc.)|Total Aset Perusahaan edgewisetx.com EWTX|RAPP - Aset Agregat Perusahaan|Nilai Agregat Aset ALMS (Alumis Inc)|Kempharm (ZVRA) - Aset Agregat Perusahaan|Gunggung Aset Perusahaan Contineum Corp|LRMR (Larimar Therapeutics) - Total Aset Perusahaan|Total Aset Perusahaan Capricor|Gunggung Aset Perusahaan TRDA (Entrada Therapeutics, Inc.)|PTHS (Channel Therapeutics Inc.) - Nilai Agregat Aset|Aset Agregat Perusahaan MediciNova MNOV|SER: Total Aset Bisnis|BioXcel Therapeutics - Total Aset Perusahaan|Aset Perusahaan ProMIS Neurosciences|APUS (apimedsus.com) - Gunggung Aset Perusahaan|AEON Biopharma, Inc. (AEON) - Total Aset Perusahaan|Aset Agregat Perusahaan Bionomics Ltd.|HUGE: Nilai Agregat Aset|Aset Agregat Perusahaan Reata Pharmaceuticals (RETA)